These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5029421)

  • 1. Microsomal enzymes and potentiation of tyramine pressor response.
    Renton KW; Eade NR
    Biochem Pharmacol; 1972 May; 21(10):1393-402. PubMed ID: 5029421
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    Eade NR; Renton KW
    Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.
    Simpson GM; Gratz SS
    Clin Pharmacol Ther; 1992 Sep; 52(3):286-91. PubMed ID: 1526086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of microsomal 5'-nucleotidase and cellular ribonucleases in rat liver after phenobarbital administration.
    Seifert J; Vácha J
    Chem Biol Interact; 1970 Dec; 2(4):297-307. PubMed ID: 5524091
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between phenylpropanolamine and monoamine oxidase inhibitors.
    D'Mello A
    J Pharm Pharmacol; 1969 Sep; 21(9):577-80. PubMed ID: 4390334
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans.
    Cusson JR; Goldenberg E; Larochelle P
    J Clin Pharmacol; 1991 May; 31(5):462-7. PubMed ID: 2050833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of tetrahydrofuran on the microsomal monooxygenase system in vitro and in vivo].
    Kozlovskaia NE; Grishanova AIu; Mishin VM; Liakhovich VV
    Biokhimiia; 1992 Dec; 57(12):1841-6. PubMed ID: 1294255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatic mixed-function oxidase activity in vitro and in vivo by various thiono-sulfur-containing compounds.
    Hunter AL; Neal RA
    Biochem Pharmacol; 1975 Dec; 24(23):2199-205. PubMed ID: 2176
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of some derivatives of pyrazolinone on the pressor activity of tyramine].
    Patané S; Arrigo Reina R
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1081-3. PubMed ID: 5374943
    [No Abstract]   [Full Text] [Related]  

  • 12. [Induction of hepatic microsomal hydroxylases. II. Reversibility, reproducibility of induction in rats pretreated with phenobarbital].
    Buchel L; Levy J
    Therapie; 1970; 25(1):107-23. PubMed ID: 5436793
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL; Grewal RS
    Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.
    Martini A; Bonollo L; Nicolis FB; Sega R; Palermo A; Braibanti E
    Br J Clin Pharmacol; 1981 Jun; 11(6):605-10. PubMed ID: 7272177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monooxygenase drug metabolizing activity in CaCl 2 -aggregated hepatic microsomes from rat liver.
    Kupfer D; Levin E
    Biochem Biophys Res Commun; 1972 May; 47(3):611-8. PubMed ID: 4402636
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetic experiments on the synergistic effect of NADH on microsomal drug oxidation.
    Netter KJ; Illing HP
    Xenobiotica; 1974 Sep; 4(9):549-61. PubMed ID: 4372813
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of metyrapone on cellular respiration and microsomal drug oxidation.
    Kahl GF; Netter KJ
    Biochem Pharmacol; 1970 Jan; 19(1):27-34. PubMed ID: 5507642
    [No Abstract]   [Full Text] [Related]  

  • 18. [Excitormotor effects of tryptamine, in presence of IMAO, in mice pretreated with enzymatic inducers].
    Denys A; Levy J; Michel-Ber E
    Therapie; 1969; 24(5):907-22. PubMed ID: 4391432
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the activation of dopa decarboxylase and other cytoplasmic liver enzymes by inducers of microsomal enzymes].
    Palm D; Ernzerhoff C; Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(4):352-71. PubMed ID: 4174080
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of alkyl phosphorothioates on the hepatic microsomal mixed-function oxidase system in rats. Inhibition of drug-metabolizing enzyme activity and selective increase of NADPH-cytochrome c reductase activity.
    Furukawa N; Sato M; Suzuki Y
    Biochem Pharmacol; 1986 Mar; 35(6):1019-26. PubMed ID: 3082332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.